tiprankstipranks
pc:allin

Allink Biotherapeutics

Shanghai, CN
https://www.allinkbio.com/
Allink Biotherapeutics is a clinical-stage biotechnology company focused on developing next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics. The company is advancing its global Phase I/II clinical programs and expanding its global footprint, aiming to innovate in the field of targeted cancer therapies.

Leadership & Board

Current Number of Employees9
Current LinkedIn Followers228

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$131M
Total Amount Raised$131M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$89M
Latest Funding Amount$89M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

Allink Biotherapeutics had 9 employees as of April 6, 2026. The number of employees increased by 0 (0.00%) week-over-week.
9Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Allink Biotherapeutics had 228 followers as of April 6, 2026. The number of followers increased by 1 (0.44%) week-over-week.
228Latest Followers Count
1(0.44%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Dec 16, 2025
Series A
$89.00M
Dec 28, 2024
Series A
$42.00M

Investors

Investor Name
Funding Round

Related News and Analysis